|Articles|August 26, 2019
AAE Empowers HCP Identification by MS
Author(s)Cygnus Technologies
AAE and MS integration enables comprehensive HCP analysis, facilitates process development, and helps determine whether your HCP ELISA is fit for purpose of process monitoring and product lot release.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
2
Why Product-Specific Strategies Matter in Advanced Therapy Manufacturing (Part 3)
3
Everything to Know About Cell and Gene Therapy in 2025
4
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
5
